CHRISTOPHER HARRIS: Open Payments
NPI 1851716831 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,388 in 180 payments from 14 companies in 2025. Trend: 2023 $2,364 · 2024 $2,489 · 2025 $3,388
Food & beverage: $3,239Travel & lodging: $142Education: $8
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 17 | $616 |
| Otsuka America Pharmaceutical, Inc. | 18 | $362 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $354 |
| ABBVIE INC. | 18 | $345 |
| Neurocrine BioSciences, Inc. | 18 | $330 |
| Alkermes, Inc. | 14 | $290 |
| Axsome Therapeutics, Inc. | 6 | $201 |
| Teva Pharmaceuticals USA, Inc. | 18 | $195 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $191 |
| Vanda Pharmaceuticals Inc. | 16 | $168 |
Products named: SPRAVATO, REXULTI, CAPLYTA, VRAYLAR, INGREZZA, ARISTADA, Auvelity, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
